期刊文献+

氨茶碱/壳聚糖/β-环糊精肺部缓释微球对呼吸道粘膜的影响 被引量:3

Mucociliotoxicity of theophylline/chitosan/β-cyclodextrin microspheres as a sustained pulmonary delivery
原文传递
导出
摘要 目的探讨氨茶碱/壳聚糖/β-环糊精微球肺部缓释微球的呼吸道粘膜毒性。方法通过测定氨茶碱/壳聚糖/β-环糊精微球肺部给药后肺泡灌洗液乳酸脱氢酶活性和总蛋白及纤毛毒性实验,对其安全性进行评价。结果氨茶碱/壳聚糖/β-环糊精微球的纤毛持续运动时间为512.33 min,纤毛运动频率为96.0%,表明其有良好的生理适应性;氨茶碱/壳聚糖/β-环糊精微球气管给药后总蛋白含量增加,乳酸脱氢酶(LDH)活性与正常组和阴性对照组差异不明显。结论氨茶碱/壳聚糖/β-环糊精微球对呼吸道粘膜无明显毒性,可作为肺部给药载体。 Objective To explore mucociliotoxicity of theophylline/chitosan/β-cyclodextrin microspheres as pulmonary sustained drug delivery carriers.Methods An acute cell toxicity experiment(LDH and protein in BALF) and a mucociliotoxicity experiment were carried out.Results Ciliary movement time of MS B microspheres was 512.33 minutes and ciliary beat frequency was 96.0%.The total contents of protein and LDH in BALF of the pulmonary delivery group were not significantly different from those of the control group.Concl...
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第9期21-24,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助项目(Y2008F15) 潍坊医学博士基金资助项目(KB200704)
关键词 氨茶碱 壳多糖 微球体 生物相容性 Aminophylline Chitin Microspheres Biocompability
  • 相关文献

参考文献2

二级参考文献8

  • 1蒋新国,崔景斌,方晓玲,韦阳,奚念朱.药物的鼻粘膜纤毛毒性及评价方法[J].药学学报,1995,30(11):848-853. 被引量:87
  • 2许庚,中华耳鼻咽喉科杂志,1989年,24卷,24页
  • 3Su K S B,J Pharm Sci,1985年,74卷,394页
  • 4Anwar A, Hussain. Intranasal drug delivery [J]. Adv Drug Del Rev, 1998,29: 39~49.
  • 5Illum L. Transport of drugs from the nasal cavity to the central nervous system[J]. Eur J Pharm Sci, 2000,11 : 1~18.
  • 6Lena PM. Microspheres as nasal drug delivery system[J]. Adv Drug Del Rev, 1998,29:185 ~ 194.
  • 7Lim ST, Mrtin GP, Berry DJ, et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan[J]. J of Controlled Release, 2000, 66:281~292.
  • 8Smart JD, Kellaway IW, Worthington HEC. An in vitro investigation of mucosal adhesive materials for use in controlled drug delivery[J]. J Pharm Pharmacol, 1984,36:295.

共引文献90

同被引文献23

  • 1Hardiman KM, Lindsey JR, Matalon S. Lack of amiloridesensitive transport across alveolar and respiratory epithelium of iNOS(-/-) mice in vivo[J]. Am J Physiol Lung Cell Mol Physiol, 2001, 281(3): L722.
  • 2Sakuma T, Gu X, Sugita M, et al. Catecholamine clearance from alveolar spaces of rat and human lungs[J]. Respiration, 2005, 72(2): 189.
  • 3Norlin A, Lu LN, Guggino SE, et al. Contribution of amiloride-insensitive pathways to alveolar fluid clearance in adult rats[J]. J Appl Physiol, 2001, 90(4): 1489.
  • 4Chen CL, Wang YM, Liu CF, et al. The effect of watersoluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation [J]. Biomaterials, 2008, 29(14): 2173.
  • 5Han DY, Nie HG, Gu X, et al. K+ channel openers restore verapamil-inhibited lung fluid resolution and transepithelialion transport. Respir Res, 2010, 11:65.
  • 6Chen CL, Wang YM, Liu CF, et al. The effect of water-solu- ble chitosan on maerophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials, 2008,29(14) :2173-2182.
  • 7Matthay MA, Robriquet L, Fang X. Alveolar epithelium: role in lung fluid balance and acute lung injury. Proe Am Tho- rac Soc, 2005,2(3) :206-213.
  • 8Matalon S, Benos DJ, Jackson RM, et al. Biophysical and molecular properties of amiloride-inhibitable Na+ channels in alveolar epithelial cells. Am J Physiol, 1996, 271 : 11-22.
  • 9Yamamoto H. Kuno Y, Sugimoto S. et aJ. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tightJuncuonsJ J].J Control Release ,2005.102 :373 - 381.
  • 10Okamoto' H . Nishida S, Todo H, et al. Pulmonary gene delivery by chi?tosan-pDNA complex powder prepared by a supercruical carbon diox?ide proccss[J]./ntJ Plwrm.,2003,92(2) :371 -380.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部